Appili Therapeutics Inc (APLI) — Capital Reinvestment Ratio

Latest as of March 2025: 0.00x

Appili Therapeutics Inc (APLI) has a Capital Reinvestment Ratio of 0.00x as of March 2025, meaning it reinvests 0% of its operating cash flow (CA$1.03 Million) in capital expenditures (CA$2.36K). Check APLI goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

CA$1.03 Million

CAD

Capital Expenditures

CA$2.36K

CAD

Data as of

Mar 2025

Most recent filing

Appili Therapeutics Inc Capital Reinvestment Ratio (2025–2025)

This chart tracks Appili Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see APLI cash generation efficiency.

Annual Capital Reinvestment Ratio for Appili Therapeutics Inc (2025–2025)

Year-by-year Capital Reinvestment Ratio for Appili Therapeutics Inc from 2025 to 2025. See APLI cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change
2025	0.00x	CA$868.82K	CA$2.36K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow